Progyny (PGNY) Competitors $20.59 +0.04 (+0.19%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$20.93 +0.34 (+1.65%) As of 10/3/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. GH, RDNT, BTSG, OPCH, SHC, WGS, SGRY, PRVA, VCYT, and HTFLShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Option Care Health (OPCH), Sotera Health (SHC), GeneDx (WGS), Surgery Partners (SGRY), Privia Health Group (PRVA), Veracyte (VCYT), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. Progyny vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Option Care Health Sotera Health GeneDx Surgery Partners Privia Health Group Veracyte Heartflow Progyny (NASDAQ:PGNY) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Does the media favor PGNY or GH? In the previous week, Guardant Health had 6 more articles in the media than Progyny. MarketBeat recorded 10 mentions for Guardant Health and 4 mentions for Progyny. Progyny's average media sentiment score of 0.71 beat Guardant Health's score of 0.27 indicating that Progyny is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Is PGNY or GH more profitable? Progyny has a net margin of 4.28% compared to Guardant Health's net margin of -49.93%. Progyny's return on equity of 10.69% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Progyny4.28% 10.69% 7.12% Guardant Health -49.93%N/A -28.95% Which has more risk and volatility, PGNY or GH? Progyny has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Which has better valuation and earnings, PGNY or GH? Progyny has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.24B1.43$54.34M$0.5934.90Guardant Health$828.85M9.45-$436.37M-$3.35-18.76 Do institutionals & insiders have more ownership in PGNY or GH? 94.9% of Progyny shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer PGNY or GH? Progyny currently has a consensus price target of $25.44, indicating a potential upside of 23.58%. Guardant Health has a consensus price target of $65.75, indicating a potential upside of 4.63%. Given Progyny's higher possible upside, equities research analysts clearly believe Progyny is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.70Guardant Health 1 Sell rating(s) 0 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 2.96 SummaryProgyny beats Guardant Health on 11 of the 16 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.77B$8.12B$6.08B$10.55BDividend YieldN/A2.82%5.68%4.70%P/E Ratio34.9075.2678.0526.71Price / Sales1.4340.42577.94179.90Price / Cash59.5523.1137.7961.25Price / Book4.156.7612.556.56Net Income$54.34M$250.93M$3.31B$277.70M7 Day Performance-4.05%2.29%4.28%2.41%1 Month Performance-12.61%3.56%7.85%9.30%1 Year Performance26.32%10.50%71.37%31.22% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny3.9295 of 5 stars$20.59+0.2%$25.44+23.6%+30.2%$1.77B$1.24B34.90310GHGuardant Health3.7275 of 5 stars$59.78+1.1%$59.00-1.3%+188.3%$7.38B$739.02M-17.842,021Analyst ForecastRDNTRadNet2.8633 of 5 stars$75.64-1.0%$76.80+1.5%+14.7%$5.88B$1.83B212.3311,021Positive NewsBTSGBrightSpring Health Services2.1727 of 5 stars$27.60+1.1%$27.10-1.8%+92.7%$4.84B$11.27B36.9035,000OPCHOption Care Health4.8786 of 5 stars$28.67+1.3%$35.75+24.7%-6.1%$4.59B$5.00B19.668,088Positive NewsAnalyst ForecastSHCSotera Health2.5842 of 5 stars$16.14+3.3%$16.00-0.9%+2.4%$4.44B$1.10B24.813,000Analyst ForecastWGSGeneDx2.4632 of 5 stars$129.79+0.1%$104.13-19.8%+151.0%$3.72B$305.45M85.271,200Analyst DowngradeSGRYSurgery Partners3.157 of 5 stars$21.87+1.2%$32.88+50.3%-32.2%$2.77B$3.11B34.8715,000Positive NewsPRVAPrivia Health Group3.4513 of 5 stars$22.90+2.4%$28.58+24.8%+38.8%$2.75B$1.74B203.361,140VCYTVeracyte3.345 of 5 stars$33.93-0.5%$40.90+20.5%+9.2%$2.68B$445.76M37.08790HTFLHeartflowN/A$31.43-4.4%$36.60+16.4%N/A$2.67BN/A0.00699Gap Up Related Companies and Tools Related Companies Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Option Care Health Alternatives Sotera Health Alternatives GeneDx Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Veracyte Alternatives Heartflow Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGNY Stock Alerts